Immunomedics, Inc. (IMMU)

85.25
NASDAQ
Prev Close 85.52
Day Low/High 85.16 / 85.48
52 Wk Low/High 8.80 / 86.91
Exchange NASDAQ
Shares Outstanding 231.16B
Market Cap 19.77B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Jim Cramer: Is This Market Undervalued?

Jim Cramer: Is This Market Undervalued?

Stocks are reasonable. Or even cheap. There will be more sell-offs ahead but remember this day and do not get too negative.

Spate of Deal News Juices Start of This Week's Trading

Spate of Deal News Juices Start of This Week's Trading

We've become accustomed lately to gap-up opens on Mondays, but some fresh acquisition agreements are helping drive this Monday's action.

7 Drug Stocks With the Right Medicine for Investors

7 Drug Stocks With the Right Medicine for Investors

These pharmaceutical favorites continue to make progress on a number of fronts including a Covid-19 vaccine.

Responding to a Subscriber Question About Immunomedics

Responding to a Subscriber Question About Immunomedics

What does the upside or the downside look like?

M&A Appetite in Pharma Has Proved Potent: Chart of the Day

M&A Appetite in Pharma Has Proved Potent: Chart of the Day

With total deals trending toward hundreds of billions, investors may be eager to bet on who's next to be acquired.

2 Biotech Names See Directors Direct Cash to Their Shares

2 Biotech Names See Directors Direct Cash to Their Shares

The stock purchases by the insiders are at companies developing treatments for breast cancer and schizophrenia.

The Charts of Immunomedics Look Very Bullish Now

The Charts of Immunomedics Look Very Bullish Now

Let's look at the charts and indicators to come up with a formula for success.

Revance Therapeutics Soars on Phase 3 Data -- Biotech Movers

Revance Therapeutics Soars on Phase 3 Data -- Biotech Movers

The Newark, Calif.-based firm unveiled positive top-line results from a pair of studies evaluating RT002 for the treatment of glabellar, or frown, lines.

Kite Takeover by Gilead Lifts Biotech Stocks

Kite Takeover by Gilead Lifts Biotech Stocks

The key to dealing with this environment is to keep an open mind.

Bullish and Bearish Reversals for This Week

Bullish and Bearish Reversals for This Week

Financial names populate the bullish side.

Activist VenBio Wins Control of Immunomedics Board

Activist VenBio Wins Control of Immunomedics Board

VenBio gained four seats on Immunomedics' board of directors.

Activist Investor to Block Partnership of Immunomedics and Seattle Genetics

Activist Investor to Block Partnership of Immunomedics and Seattle Genetics

The largest shareholder of Immunomedics, VenBio, asks for an injunction against its partnership with Seattle Genetics.

The Sale of Immunomedics Hinges on This

The Sale of Immunomedics Hinges on This

Immunomedics has been for sale for quite some time, but there hasn't been any interest in it. Here's why.

Immunomedics downgradeded at Jefferies

Why Worry About the Big Picture?

Why Worry About the Big Picture?

There are 280 stocks hitting new highs.

What Shutdown?

What Shutdown?

This market refuses to stay down for long.

Bulls Stay on a Roll

Bulls Stay on a Roll

They score yet another V-shaped bounce.